You are currently viewing a new version of our website. To view the old version click .
Hematology Reports
  • Hematology Reports is published by MDPI from Volume 14 Issue 1 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
  • Brief Report
  • Open Access

30 August 2011

Development of Diffuse Large B-Cell Lymphoma in a Patient with Waldenström’s Macroglobulinemia/Lymphoplasmacytic Lymphoma: Clonal Identity between Two B-Cell Neoplasms

,
,
,
,
,
,
,
and
1
Department of Hematolog, Tokyo Women's Medical University, 8-1, Kawada- cho, Shinjuku-ku, Tokyo 162-8666, Japan
2
Department of Surgical Pathology, Tokyo Women’s Medical University, 8-1, Kawada- cho, Shinjuku-ku, Tokyo 162-8666, Japan
3
Division of Hematology, KKR Suifu Hospital, Ibaraki 311-4141, Japan
4
Division of Hematology/Oncology and Transfusion Medicine, KKR Suifu Hospital, Ibaraki 311-4141, Japan

Abstract

Waldenström’s macroglobulinemia (WM)/ lymphoplasmacytic lymphoma (LPL) is an indolent mature B-cell neoplasm. In rare cases of WM/LPL, diffuse large B-cell lymphoma (DLBCL) develops as a result of histologic transformation. In this report, we present a case of DLBCL developing in a patient with WM/LPL. Combination chemotherapy for DLBCL was effective and complete remission was eventually achieved. We attempted to determine the clonal relatedness between WM/LPL and DLBCL in the patient by analyzing complementarity-determining region 3 (CDR3) in the immunoglobulin heavy chain gene. A common CDR3 sequence was found in tumor cells of DLBCL and those of WM/LPL, indicating that tumor cells of DLBCL are clonally identical to those of WM/LPL. Therefore, in the present case, DLBCL is developed from WM/LPL cells by clonal evolution.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.